Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Burundi has been on the rise in recent years due to several factors.
Customer preferences: Burundians have become increasingly aware of the importance of vaccines in preventing diseases. This has led to a growing demand for vaccines, especially among parents who want to protect their children from preventable illnesses. Additionally, the government has been actively promoting vaccination campaigns, which has also contributed to the increasing demand.
Trends in the market: The vaccines market in Burundi has seen a shift towards more advanced and effective vaccines. In the past, many vaccines used in the country were outdated and less effective. However, in recent years, there has been a trend towards using newer and more effective vaccines, which has led to better health outcomes for the population.
Local special circumstances: Burundi is a low-income country with limited resources, which has posed challenges for the vaccines market. The cost of vaccines can be a barrier for many people, and the government has had to rely on external funding to support its vaccination campaigns. Additionally, the country has faced political instability and conflict, which has made it difficult to implement vaccination programs in some areas.
Underlying macroeconomic factors: The Burundian economy has been growing slowly in recent years, which has limited the government's ability to invest in healthcare infrastructure and vaccination programs. Additionally, the country has a high poverty rate, which can limit access to healthcare services, including vaccines. However, there has been some progress in improving healthcare access, and the government has been working to expand its vaccination programs to reach more people.In conclusion, the vaccines market in Burundi has been developing in response to increasing awareness of the importance of vaccines, a shift towards more effective vaccines, and government efforts to promote vaccination campaigns. However, challenges such as limited resources, political instability, and poverty continue to pose obstacles to the growth of the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
